Litcius/Paper detail

Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials

Ching-Yi Chen, Wang‐Chun Chen, Chi‐Kuei Hsu, Chien‐Ming Chao, Chih‐Cheng Lai

2021International Immunopharmacology31 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAdverse effectRandomized controlled trialMeta-analysisInternal medicinePlaceboJanus kinaseClinical trialPathologyCytokineAlternative medicineCytokine Signaling Pathways and Interactionsinterferon and immune responsesCOVID-19 Clinical Research Studies
Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials | Litcius